Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery

PHASE2RecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Postoperative HypoalbuminemiaPostoperative ComplicationsGastric Cancer
Interventions
DRUG

Human Serum Albumin Infusion for LAT Group

Participants in this group will receive human serum albumin infusion when their serum albumin level falls below 25 g/L. The infusion is goal-oriented, with the aim of maintaining albumin levels above 25 g/L during the postoperative period. The dose is calculated based on the albumin deficit and patient weight to ensure optimal therapeutic effect.

DRUG

Human Serum Albumin Infusion for HAT Group

Participants in this group will receive human serum albumin infusion when their serum albumin level falls below 30 g/L. The intervention aims to maintain albumin levels above 30 g/L during the postoperative period. The dose is similarly calculated based on the albumin deficit and patient weight.

Trial Locations (1)

130021

RECRUITING

First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER